Liping Wu

467 total citations
25 papers, 312 citations indexed

About

Liping Wu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Liping Wu has authored 25 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cancer Research. Recurrent topics in Liping Wu's work include Thyroid Disorders and Treatments (9 papers), RNA modifications and cancer (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Liping Wu is often cited by papers focused on Thyroid Disorders and Treatments (9 papers), RNA modifications and cancer (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Liping Wu collaborates with scholars based in China, Germany and United States. Liping Wu's co-authors include Yuan Shao, Xi Ding, Junli Li, Fengyi Zhao, Bingyin Shi, Meng Zhang, Mingqian He, Yuan Zhao, Ling Guo and Meng Li and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Carbon.

In The Last Decade

Liping Wu

24 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liping Wu China 11 132 103 92 45 29 25 312
Daniela Virginia Frau Italy 11 78 0.6× 116 1.1× 39 0.4× 44 1.0× 49 1.7× 21 273
Ana Mompeón Spain 10 164 1.2× 77 0.7× 120 1.3× 12 0.3× 43 1.5× 18 383
Martina Mandarano Italy 10 112 0.8× 57 0.6× 54 0.6× 28 0.6× 16 0.6× 36 383
Yingfeng Tu China 11 217 1.6× 28 0.3× 90 1.0× 71 1.6× 31 1.1× 18 385
Jorge F. Haller United States 7 99 0.8× 116 1.1× 64 0.7× 8 0.2× 68 2.3× 15 333
Chifei Kang United States 9 215 1.6× 30 0.3× 67 0.7× 19 0.4× 53 1.8× 12 336
Wenting Xuan China 9 121 0.9× 38 0.4× 53 0.6× 43 1.0× 41 1.4× 13 280
Steve T. Yeh United States 9 224 1.7× 32 0.3× 21 0.2× 46 1.0× 41 1.4× 18 384
Yajie Yu China 11 118 0.9× 13 0.1× 61 0.7× 24 0.5× 26 0.9× 36 337

Countries citing papers authored by Liping Wu

Since Specialization
Citations

This map shows the geographic impact of Liping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liping Wu more than expected).

Fields of papers citing papers by Liping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liping Wu. The network helps show where Liping Wu may publish in the future.

Co-authorship network of co-authors of Liping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Liping Wu. A scholar is included among the top collaborators of Liping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liping Wu. Liping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Liping Wu, Yingying Du, et al.. (2025). M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy. Vaccines. 13(4). 412–412. 1 indexed citations
2.
Jin, Jianguo & Liping Wu. (2025). Clinical Value of Low-Dose Spiral CT Combined with Serum CEA in the Differential Diagnosis of Early Lung Cancer. Cancer Management and Research. Volume 17. 1421–1432.
3.
Peng, Yu‐Hui, Anqi Ni, Liping Wu, et al.. (2024). Nitrogen-doped Co/carbon nanosheet composites with accordion-like structures and superior magnetic resonance for broadband electromagnetic wave absorption. Carbon. 234. 119965–119965. 16 indexed citations
4.
Wu, Liping, et al.. (2024). Fructose-1, 6-Bisphosphate Aldolase B Suppresses Glycolysis and Tumor Progression of Gastric Cancer. Digestive Diseases and Sciences. 69(9). 3290–3304. 1 indexed citations
5.
Wu, Liping, Weili Quan, Yi Zhang, et al.. (2022). Attenuated Duck Hepatitis A Virus Infection Is Associated With High mRNA Maintenance in Duckling Liver via m6A Modification. Frontiers in Immunology. 13. 839677–839677. 7 indexed citations
6.
Wu, Liping, et al.. (2021). Farnesol Promotes Apoptosis and Inhibits Invasion of Nasopharyngeal Carcinoma Cells. Current Topics in Nutraceutical Research. 20(2). 321–327. 1 indexed citations
7.
Ding, Xi, Rui Li, Liping Wu, et al.. (2021). Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population. BMC Endocrine Disorders. 21(1). 39–39. 6 indexed citations
8.
Wang, Li‐Fang, et al.. (2021). LncRNA AC079630.4 expression associated with the progression and prognosis in lung cancer. Aging. 13(14). 18658–18668. 9 indexed citations
9.
Zhang, Meng, Xi Ding, Liping Wu, et al.. (2020). A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit. Thyroid. 31(4). 638–648. 28 indexed citations
10.
Wu, Liping, et al.. (2020). Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Free Radical Biology and Medicine. 153. 140–158. 23 indexed citations
11.
Yan, Chunxiao, Liping Wu, Hangyu Wang, et al.. (2020). LncRNA HULC shRNA disinhibits miR-377-5p to suppress the growth and invasion of hepatocellular carcinoma in vitro and hepatocarcinogenesis in vivo. Annals of Translational Medicine. 8(20). 1294–1294. 18 indexed citations
12.
Gao, Shan, Dayuan Li, Xuegong Shi, et al.. (2020). MiR-182-5p Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by ox-LDL Through Targeting PAPPA. International Heart Journal. 61(4). 822–830. 20 indexed citations
13.
Li, Junli, et al.. (2019). SNHG15 functions as a tumor suppressor in thyroid cancer. Journal of Cellular Biochemistry. 120(4). 6120–6126. 24 indexed citations
14.
Wu, Liping, et al.. (2019). Cod Skin Oligopeptide Inhibits Human Gastric Carcinoma Cell Growth by Inducing Apoptosis. Nutrition and Cancer. 72(2). 218–225. 3 indexed citations
15.
Wu, Liping, Tadayuki Oshima, Katsuyuki Tozawa, et al.. (2017). Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. Journal of Neurogastroenterology and Motility. 23. 290. 4 indexed citations
16.
Wang, Zhenhua, et al.. (2016). Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy. Tumor Biology. 37(9). 11825–11833. 8 indexed citations
17.
18.
Wu, Liping, Bingyin Shi, Jing Yang, et al.. (2011). Gender difference in the establishment of animal model of Graves′ disease. Zhonghua neifenmi daixie zazhi. 27(6). 505–508. 1 indexed citations
19.
Wu, Liping, Jing Yang, Li Xu, et al.. (2011). Induction of Murine Neonatal Tolerance Against Graves' Disease Using Recombinant Adenovirus Expressing the TSH Receptor A-Subunit. Endocrinology. 152(3). 1165–1171. 18 indexed citations
20.
Ye, Feng, Peng Hou, Xiaoyan Wu, et al.. (2011). The significance of immune-related molecule expression profiles in an animal model of Graves' disease. Autoimmunity. 45(2). 143–152. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Virginia Frau Breakdown of academic impact, for papers by Ana Mompeón Breakdown of academic impact, for papers by Martina Mandarano Breakdown of academic impact, for papers by Yingfeng Tu Breakdown of academic impact, for papers by Jorge F. Haller Breakdown of academic impact, for papers by Chifei Kang Breakdown of academic impact, for papers by Wenting Xuan Breakdown of academic impact, for papers by Steve T. Yeh Breakdown of academic impact, for papers by Yajie Yu
Rankless by CCL
2026